NCT03762395View on ClinicalTrials.gov

Anti Inflammatory Lipid Mediators in Asthma Lipid Anti-Inflammtory Mediators in Asthma

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 8, 2023

Primary Completion Date

November 30, 2029

Study Completion Date

January 30, 2030

Conditions
AsthmaObesity
Interventions
DRUG

CXA-10

6 weeks of treatment with 150 mg/day of orally administered CXA-10

DRUG

Matching Placebo

6 weeks of treatment with orally administered matching placebo (to 150 mg/day of CXA-10)

Trial Locations (1)

80045

RECRUITING

University of Colorado Anschutz Medical Campus, Aurora

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Colorado, Denver

OTHER